Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

OMER, BTH, AVOT, BLT - Stock Watch On Omeros, Blyth, American Video Teleconferencing and Blount!




American Video Teleconferencing Corp. (Pink Sheets:AVOT) is pleased to announce that it has hired a French speaking geologist to search the archives of the Quebec Department of Mines for Rare Earths showings not on a current computer file. The company believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings. As neither the Federal nor Quebec Governments have carried out any air borne surveys in this area, the company will seek a contractor to do an air borne Mag-EM radiometric survey. This survey will cover its present holdings and the immediate surrounding area looking for future acquisitions. We are pleased to be working in the Province of Quebec as it is rated the number one jurisdiction in the world to carry out mineral exploration. The Quebec Government gives a rebate up to 45% for property expenditures.

Presently the company is in the final stage of negotiations with Kondor Gold Pyt. in Australia.

The company will aggressively continue to search world-wide for opportunities in Precious, Base and Rare Earths metal projects.

The world is currently dependent on China for its industrial and military requirements, and China is talking advantage of this need through the use of economic blackmail, by creating price increases and blocking shipments to create shortages.

America has allowed itself to be placed in a position where we are dependent on China for almost all of our goods, including military, though it wasn't a smart move, the question remains what have we as a nation learned, if anything?

Now some companies are beginning to look into the Rare Earth Mineral needs of not only America, but the world, and this company, American Video Teleconferencing Corp., appears to have a real interest in making a difference as they are actively searching for these minerals.


Blount International, Inc. (NYSE:BLT) announced results for the third quarter ended September 30, 2010, and updated its full year financial outlook for 2010.

The Company’s sales in the third quarter of 2010 were $162.6 million, a 28.1% increase from the third quarter of 2009. Operating income for the third quarter of 2010 was $20.7 million compared to $20.2 million in the third quarter of 2009. Third quarter income from continuing operations was $10.6 million ($0.22 per diluted share) compared to $11.0 million ($0.23 per diluted share) in the third quarter of 2009.


Blyth, Inc. (NYSE:BTH), a leading multi-channel designer and marketer of home fragrance products, home decor products and household convenience items, recently announced that it has declared a semi-annual cash dividend of $0.10 per share on the Company’s common stock for the six months ended July 31, 2010. This represents an amount equal to the dividend paid in the comparable prior year period. The semi-annual dividend, authorized at the September 15, 2010 Board of Directors meeting, will be payable to shareholders of record as of November 1, 2010 and will be paid on November 15, 2010.

Blyth, Inc., headquartered in Greenwich, CT, USA, is a Home Expressions company that markets an extensive array of home fragrance products, decorative accessories, seasonal decorations and household convenience items. The Company sells its products through multiple channels of distribution, including the home party plan method of direct selling and one-on-one direct selling, as well as through the wholesale and catalog/Internet channels. Blyth also markets tabletop lighting and chafing fuel for the Away From Home or foodservice trade.


Omeros Corporation (Nasdaq:OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, has been awarded non-taxable grants totaling approximately $1.7 million under the Qualifying Therapeutic Discovery Project (QTDP) included in the Patient Protection and Affordable Health Care Act of 2010.

Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company’s most clinically advanced product candidates are derived from its proprietary PharmacoSurgery platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has five ongoing clinical development programs, including four from its PharmacoSurgery platform, the most advanced of which is in a Phase 3 clinical program, and one from its Addiction program. Omeros may also have the near-term capability, through its GPCR program, to add wholly new drug targets to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of antibody and small-molecule preclinical programs targeting inflammation and central nervous system disorders.



Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) anticipates to receive 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (OTCPK:AVOT) from the company for 12 months IR Services